NextCure Inc. (NXTC) PT Lowered to $6 at Piper Sandler
Tweet
Share
E-mailGet Alerts NXTC Hot Sheet
Price: $6.65 -13.75%
Rating Summary:
8 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Rating Summary:
8 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Join SI Premium – FREE
Piper Sandler analyst Edward Tenthoff lowered the price target on NextCure Inc. (NASDAQ: NXTC) to $6.00 (from $13.00) while maintaining a rating.
You May Also Be Interested In
- Marvell (MRVL) PT Raised to $225 at TD Cowen
- DeFi Technologies (DEFT) PT Lowered to $1 at Benchmark Following Q2 Miss
- Home Depot (HD) PT Lowered to $407 at BofA Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
